Besides selective estrogen receptor modulators like tamoxifen, ClinOmicsTrailbc also provides an in-depth assessment of the most relevant targeted drug classes for breast cancer treatment (cf. Fig. 5). This evidence concerns the gene ESR1 and breast cancer.